Model
Edge
Vir Biotechnology Inc.
VIR
Filing Type
10-K
Filing Date
2/26/2025
Updated
2/26/25, 3:34 PM
Filing
10-K
Earnings Release
Exhibits
10-K
FY 2023
EX-10.8
EX-10.8 NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
EX-10.9
EX-10.9 DISCRETIONARY BONUS PLAN
EX-10.12
EX-10.12 PROMOTION LETTER (VANINA DE VERNEUIL)
EX-10.13
EX-10.13 OFFER LETTER (MARK EISNER)
EX-10.15
EX-10.15 CHANGE IN CONTROL AND SEVERANCE BENEFIT PLAN
EX-19
EX-19 INSIDER TRADING POLICY
EX-21.1
EX-21.1 SUBSIDIARIES
EX-23.1
EX-23.1 EY CONSENT
EX-31.1
EX-31.1
EX-31.2
EX-31.2
EX-32.1
EX-32.1
GRAPHIC
GRAPHIC_PIPELINE
GRAPHIC
GRAPHIC_MECHANISM OF TOBEVIBART AND ELEBSIRAN
GRAPHIC
GRAPHIC_MABS AND TCES SIMILARITIES
GRAPHIC
GRAPHIC_MAB DISCOVERY WORKFLOW
GRAPHIC
GRAPHIC_MASKING MOA
GRAPHIC
GRAPHIC_TCE STRUCTURE
GRAPHIC
GRAPHIC_COMPARISON OF CUMULATIVE TOTAL RETURNS